Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Metformin limits osteoarthritis development and progression through activation of AMPK signalling.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Metformin limits osteoarthritis development and progression through activation of AMPK signalling.
Metformin limits osteoarthritis development and progression through activation of AMPK signalling. Ann Rheum Dis. 2020 05; 79(5):635-645.
View in:
PubMed
subject areas
AMP-Activated Protein Kinases
Animals
Cartilage, Articular
Cells, Cultured
Chondrocytes
Disease Models, Animal
Disease Progression
Gene Expression Regulation
Humans
Hypoglycemic Agents
Menisci, Tibial
Metformin
Mice
Mice, Knockout
Mice, Obese
Osteoarthritis
Random Allocation
Sensitivity and Specificity
Signal Transduction
Up-Regulation
authors with profiles
Chundo Oh
Lan Zhao
Guozhi Xiao